OPEN END TURBO PUT WARRANT - AMGEN | Market Closed - Bid/Ask 13:38:09 2024-05-28 EDT | Pre-market 02:03:11 | |||
| 1.24 EUR | +9.73% |
|
1.25 | +0.81% |
| Current month | -17.88% | ||
| 1 month | -20.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-28 | 1.24 | +9.73% |
| 24-05-27 | 1.13 | -3.42% |
| 24-05-24 | 1.17 | +1.74% |
| 24-05-23 | 1.15 | +2.68% |
| 24-05-22 | 1.12 | +0.90% |
Real-time Boerse Frankfurt Warrants
Last update May 28, 2024 at 01:38 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM0JA3 |
| ISIN | DE000UM0JA31 |
| Date issued | 2024-01-10 |
| Strike | 434 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.18 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.63 € |
|---|---|
| Lowest since issue | 1.03 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
